Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study

Study Questions:

What is the added value of new biomarkers including soluble ST2 (sST2), growth differentiation factor-15 (GDF-15), and high-sensitivity troponin I (hs-TnI) for predicting cardiovascular outcomes in a community-based population?